Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70626 - 70650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	FOS	2353	upregulated	Silicon Dioxide analog results in increased expression of FOS mRNA	14q24.3	A24194
Silicon dioxide	Approved	FOS	2353	upregulated	Silicon Dioxide results in increased expression of FOS mRNA	14q24.3	A24200 A24197
Silicon dioxide	Approved	FOSB	2354	upregulated	Silicon Dioxide analog results in increased expression of FOSB mRNA	19q13.32	A24194 A24195
Silicon dioxide	Approved	FOSB	2354	upregulated	Silicon Dioxide results in increased expression of FOSB mRNA	19q13.32	A24197 A24196
Silicon dioxide	Approved	FOSL1	8061	upregulated	Silicon Dioxide analog results in increased expression of FOSL1 mRNA	11q13.1	A24195
Silicon dioxide	Approved	FOSL1	8061	downregulated	Silicon Dioxide results in decreased expression of FOSL1 mRNA	11q13.1	A24207
Silicon dioxide	Approved	FOSL1	8061	upregulated	Silicon Dioxide results in increased expression of FOSL1 mRNA	11q13.1	A24197 A24196 A24198
Silicon dioxide	Approved	FOSL2	2355	upregulated	Silicon Dioxide analog results in increased expression of FOSL2 mRNA	2p23.2	A24195
Silicon dioxide	Approved	FOXA1	3169	downregulated	Silicon Dioxide analog results in decreased expression of FOXA1 mRNA	14q21.1	A24195
Silicon dioxide	Approved	FOXA2	3170	downregulated	Silicon Dioxide analog results in decreased expression of FOXA2 mRNA	20p11.21	A24195
Silicon dioxide	Approved	FOXA3	3171	downregulated	Silicon Dioxide analog results in decreased expression of FOXA3 mRNA	19q13.32	A24195
Silicon dioxide	Approved	FOXD2	2306	downregulated	Silicon Dioxide analog results in decreased expression of FOXD2 mRNA	1p33	A24195
Silicon dioxide	Approved	FOXF1	2294	upregulated	Silicon Dioxide analog results in increased expression of FOXF1 mRNA	16q24.1	A24194
Silicon dioxide	Approved	FOXF2	2295	upregulated	Silicon Dioxide analog results in increased expression of FOXF2 mRNA	6p25.3	A24195
Silicon dioxide	Approved	FOXJ1	2302	downregulated	Silicon Dioxide analog results in decreased expression of FOXJ1 mRNA	17q25.1	A24195
Silicon dioxide	Approved	FOXJ1	2302	upregulated	Silicon Dioxide analog results in increased expression of FOXJ1 mRNA	17q25.1	A24194
Silicon dioxide	Approved	FOXJ3	22887	downregulated	Silicon Dioxide results in decreased expression of FOXJ3 mRNA	1p34.2	A24196
Silicon dioxide	Approved	FOXN3	1112	downregulated	Silicon Dioxide results in decreased expression of FOXN3 mRNA	14q31.3-q32.11	A24196
Silicon dioxide	Approved	FOXO1	2308	upregulated	Silicon Dioxide analog results in increased expression of FOXO1 mRNA	13q14.11	A24195
Silicon dioxide	Approved	FOXO4	4303	downregulated	Silicon Dioxide analog results in decreased expression of FOXO4 mRNA	Xq13.1	A24195
Silicon dioxide	Approved	FOXP2	93986	downregulated	Silicon Dioxide analog results in decreased expression of FOXP2 mRNA	7q31.1	A24195
Silicon dioxide	Approved	FOXP3	50943	downregulated	Silicon Dioxide analog results in decreased expression of FOXP3 mRNA	Xp11.23	A24195
Silicon dioxide	Approved	FOXR1	283150	downregulated	Silicon Dioxide analog results in decreased expression of FOXR1 mRNA	11q23.3	A24195
Silicon dioxide	Approved	FRAS1	80144	downregulated	Silicon Dioxide analog results in decreased expression of FRAS1 mRNA	4q21.21	A24195
Silicon dioxide	Approved	FRAS1	80144	upregulated	Silicon Dioxide analog results in increased expression of FRAS1 mRNA	4q21.21	A24194

Displaying entries 70626 - 70650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability